Advanced Biomed Inc. ADVB
6.38
0.07
1.11%
as of 25 Sep
- Market cap
- $10.4M
- P/E
- 1.3×
Follow ADVB
| Jun '24 | Jun '25 | |
|---|---|---|
Current Ratio |
1.12 | 2.09 |
Net Debt/EBITDA |
1.22 | 1.08 |
Debt/Assets |
0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 |
Asset Turnover |
— | 0.00 |
Operating CF/Net income |
0.76 | 1.79 |
Capex/Depreciation |
(0.19) | (0.09) |
Interest Coverage |
0.00 | 0.00 |
| 0.00% | (126.79%) | |
| 0.00% | (59.40%) | |
ROIC |
0.00% | (329.11%) |
Return on Tangible Assets |
(330.01%) | (93.79%) |
Research and Development Expense of Revenue |
0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.03 | 0.02 |
Free Cash Flow per Share |
(2.20) | (5.71) |
Cash per Share |
2.61 | 2.83 |
Shareholders Equity per Share |
1.66 | 3.39 |
Interest Debt per Share |
0.00 | 0.00 |
Book value per Share |
1.66 | 3.39 |
Free Cash Flow |
(2.20) | (5.86) |
Working Capital |
0.32 | 3.14 |
Capital Expenditures |
(0.07) | (0.03) |
Net Current Asset Value |
0.25 | 3.00 |
| Other line items | ||
Quick Ratio |
0.95 | 1.01 |
Depreciation/Fixed assets |
0.76 | 1.04 |
Cash ROIC |
(62.06%) | (96.47%) |
Accounts Payable Turnover |
— | 0.00 |
Average Days of Payables |
0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 |
Operating CF per Share |
(2.13) | (5.68) |
Capex per Share |
(0.07) | (0.03) |
Average Payables |
— | 2.76 |
Average Assets |
— | 5.49 |
Average Common Equity |
— | 2.57 |
Capex to Sales |
0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% |
Columns are period end dates